Tough criticisms rise as biotech matures

Thirty years ago, the business of biotechnology amounted to a handful of scientists, a few brave investors, and a bold, if unproven, idea: By tweaking genes in a lab, you could transform the process of making drugs.

Today, biotech encompasses hundreds of companies around the world and is a marquee industry in New England, where political leaders gush over its ability to create jobs and draw investment dollars to Massachusetts.

But even as biotech revels in its successes, the business is facing a new challenge: criticism for its real-world effect on healthcare spending and agriculture.

Source:  Boston Globe

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: